These results show that loss-of-function of SRSF10 in the liver is associated with decreased PPARα activity leading to increased susceptibility to NAFLD and obesity-induced metabolic dysfunction. Here, PPARA is linked to metabolic dysfunction-associated steatotic liver disease.